Australia flagARTG 395790

OPTIVE Fusion Lubricant Eye Drops - Lubricant, eye

ARTG ID: 395790 · Abbvie Pty Ltd · Allergan Sales LLC · Class III · Started September 09, 2022

Good Name: Abbvie Pty Ltd - OPTIVE Fusion Lubricant Eye Drops - Lubricant, eye

Device classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration information
ARTG ID
395790
Start Date
September 09, 2022
Effective Date
September 09, 2022
Sponsor
Manufacturer
Country
United States of America
Address
2525 Dupont Drive, Irvine, CA, 92612
Intended purpose

Intended to lubricate the surface of the eye(s) to relieve the feeling of dryness, burning, irritation, stinging, foreign body sensation and/or discomfort caused by dry eye disease or environmental factors such as dust, glare, pollen and air pollution.

About this record

Access comprehensive regulatory information for OPTIVE Fusion Lubricant Eye Drops - Lubricant, eye in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 395790 and sponsored by Abbvie Pty Ltd, manufactured by Allergan Sales LLC in United States of America. The device registration started on September 09, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free DatabasePowered by Pure Global AITGA ARTG Official Data